Show simple item record

dc.contributor.authorKouno, Takahide
dc.contributor.authorSilvas, Tania V.
dc.contributor.authorHilbert, Brendan J.
dc.contributor.authorShandilya, Shivender
dc.contributor.authorBohn, Markus-Frederik
dc.contributor.authorKelch, Brian A.
dc.contributor.authorRoyer, William E.
dc.contributor.authorSomasundaran, Mohan
dc.contributor.authorYilmaz, Nese Kurt
dc.contributor.authorMatsuo, Hiroshi
dc.contributor.authorSchiffer, Celia A.
dc.date2022-08-11T08:08:22.000
dc.date.accessioned2022-08-23T15:52:24Z
dc.date.available2022-08-23T15:52:24Z
dc.date.issued2017-04-28
dc.date.submitted2017-06-30
dc.identifier.citationNat Commun. 2017 Apr 28;8:15024. doi: 10.1038/ncomms15024. <a href="https://doi.org/10.1038/ncomms15024">Link to article on publisher's site</a>
dc.identifier.issn2041-1723 (Linking)
dc.identifier.doi10.1038/ncomms15024
dc.identifier.pmid28452355
dc.identifier.urihttp://hdl.handle.net/20.500.14038/29130
dc.description.abstractNucleic acid editing enzymes are essential components of the immune system that lethally mutate viral pathogens and somatically mutate immunoglobulins, and contribute to the diversification and lethality of cancers. Among these enzymes are the seven human APOBEC3 deoxycytidine deaminases, each with unique target sequence specificity and subcellular localization. While the enzymology and biological consequences have been extensively studied, the mechanism by which APOBEC3s recognize and edit DNA remains elusive. Here we present the crystal structure of a complex of a cytidine deaminase with ssDNA bound in the active site at 2.2 A. This structure not only visualizes the active site poised for catalysis of APOBEC3A, but pinpoints the residues that confer specificity towards CC/TC motifs. The APOBEC3A-ssDNA complex defines the 5'-3' directionality and subtle conformational changes that clench the ssDNA within the binding groove, revealing the architecture and mechanism of ssDNA recognition that is likely conserved among all polynucleotide deaminases, thereby opening the door for the design of mechanistic-based therapeutics.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28452355&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright The Author(s) 2017.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAPOBEC3A
dc.subjectcrystal structure
dc.subjectcytidine deaminase
dc.subjectBiochemistry
dc.subjectEnzymes and Coenzymes
dc.subjectMolecular Biology
dc.subjectStructural Biology
dc.titleCrystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity
dc.typeJournal Article
dc.source.journaltitleNature communications
dc.source.volume8
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2359&amp;context=faculty_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/1356
dc.identifier.contextkey10382254
refterms.dateFOA2022-08-23T15:52:24Z
html.description.abstract<p>Nucleic acid editing enzymes are essential components of the immune system that lethally mutate viral pathogens and somatically mutate immunoglobulins, and contribute to the diversification and lethality of cancers. Among these enzymes are the seven human APOBEC3 deoxycytidine deaminases, each with unique target sequence specificity and subcellular localization. While the enzymology and biological consequences have been extensively studied, the mechanism by which APOBEC3s recognize and edit DNA remains elusive. Here we present the crystal structure of a complex of a cytidine deaminase with ssDNA bound in the active site at 2.2 A. This structure not only visualizes the active site poised for catalysis of APOBEC3A, but pinpoints the residues that confer specificity towards CC/TC motifs. The APOBEC3A-ssDNA complex defines the 5'-3' directionality and subtle conformational changes that clench the ssDNA within the binding groove, revealing the architecture and mechanism of ssDNA recognition that is likely conserved among all polynucleotide deaminases, thereby opening the door for the design of mechanistic-based therapeutics.</p>
dc.identifier.submissionpathfaculty_pubs/1356
dc.contributor.departmentSchiffer Lab
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.source.pages15024


Files in this item

Thumbnail
Name:
ncomms15024.pdf
Size:
1.299Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright The Author(s) 2017.
Except where otherwise noted, this item's license is described as Copyright The Author(s) 2017.